Tri Chemical Laboratories
4369.TTSE PRIMEChemicals
Financials · Consolidated
| Fiscal year ended | 2026-01 | 2025-01 | 2024-01 | 2023-01 | 2022-01 | 2021-01 |
|---|---|---|---|---|---|---|
| Revenue | ¥23.9bn | ¥18.9bn | ¥11.2bn | ¥13.8bn | ¥11.6bn | ¥9.8bn |
| Operating income | ¥5.9bn | ¥5.3bn | ¥1.9bn | ¥3.5bn | ¥3.0bn | — |
| Ordinary income | ¥7.1bn | ¥6.6bn | ¥3.3bn | ¥6.2bn | ¥5.3bn | ¥4.3bn |
| Net income (owners) | ¥5.5bn | ¥5.0bn | ¥2.5bn | ¥4.8bn | ¥4.1bn | ¥3.4bn |
| Total assets | ¥47.3bn | ¥36.9bn | ¥31.9bn | ¥32.1bn | ¥28.3bn | ¥19.9bn |
| Net assets / equity | ¥36.1bn | ¥31.6bn | ¥27.6bn | ¥25.9bn | ¥21.3bn | ¥12.6bn |
| Operating cash flow | ¥3.8bn | ¥3.7bn | ¥3.0bn | ¥6.4bn | ¥3.6bn | ¥2.1bn |
| EPS (basic) | ¥169.72 | ¥152.69 | ¥76.03 | ¥148.7 | ¥126.33 | ¥108.08 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 14
| Period | Form | Figures |
|---|---|---|
| 2026-02-01 → 2026-07-31 | Half-year | 67 figures · EDINET |
| 2025-02-01 → 2026-01-31 | Annual | 196 figures · EDINET |
| 2025-02-01 → 2025-07-31 | Half-year | 67 figures · EDINET |
| 2024-02-01 → 2025-01-31 | Annual | 196 figures · EDINET |
| 2024-02-01 → 2024-07-31 | Half-year | 67 figures · EDINET |
| 2024-02-01 → 2024-04-30 | Quarterly Q1 | 67 figures · EDINET |
| 2023-02-01 → 2024-01-31 | Annual | 196 figures · EDINET |
| 2023-02-01 → 2023-10-31 | Quarterly Q3 | 69 figures · EDINET |
| 2023-02-01 → 2023-07-31 | Quarterly Q2 | 69 figures · EDINET |
| 2023-02-01 → 2023-04-30 | Quarterly Q1 | 67 figures · EDINET |
| 2022-02-01 → 2023-01-31 | Annual | 196 figures · EDINET |
| 2022-02-01 → 2022-10-31 | Quarterly Q3 | 69 figures · EDINET |
| 2022-02-01 → 2022-07-31 | Quarterly Q2 | 69 figures · EDINET |
| 2022-02-01 → 2022-04-30 | Quarterly Q1 | 67 figures · EDINET |
22 more reports are still being processed.